Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- University of Oslo
- Nanyang Technological University
- National University of Singapore
- City of Hope
- Harvard University
- Nature Careers
- UCL;
- University of Nottingham
- University of Sydney
- MOHAMMED VI POLYTECHNIC UNIVERSITY
- RMIT University
- UiT The Arctic University of Norway
- University of New South Wales
- Villanova University
- Aarhus University
- AbbVie
- Amgen
- Auburn University
- CSIRO
- Centre for Genomic Regulation
- Centre for Genomic Regulation (CRG)
- DAAD
- FLINDERS UNIVERSITY
- Flinders University
- King's College London
- Max Planck Institute for Heart and Lung Research, Bad Nauheim
- Monash University
- Northeastern University
- OsloMet
- RMIT UNIVERSITY
- SINGAPORE INSTITUTE OF TECHNOLOGY (SIT)
- The Francis Crick Institute;
- The University of Queensland
- UNIVERSITY OF THE SUNSHINE COAST - UNISC
- University of Colorado
- University of Leicester
- University of Lund
- University of Utah
- Université Gustave Eiffel
- Vanderbilt University
- Zukunftskolleg, University of Konstanz
- 31 more »
- « less
-
Field
-
Introduction: The PATHS study is a Ministry of Education (MOE)-funded longitudinal investigation tracking 500–600 Primary 1 students enrolled in the Learning Support Programme (LSP) and/or Learning Support for
-
. The key objectives are to support efforts to elucidating the molecular basis of type-2 diabetes, metabolic syndrome, including fatty liver disease and to track changes in inflammatory signatures and states
-
and synthesize target compounds. Conduct laboratory experiments for the synthesis of target compounds, including purification and characterization using techniques such as NMR, MS, FTIR, GC and HPLC
-
translational environment of the UCL Institute of Neurology, the ARUK UDDI is uniquely placed to find novel targets, rapidly validate identified novel targets and mechanisms, establish screens and progress
-
and Pharmacology). The Division has a track record in high-quality research across a broad range of drug discovery, pharmacy and patient safety-related areas, and for developing spinout companies
-
and Pharmacology). The Division has a track record in high-quality research across a broad range of drug discovery, pharmacy and patient safety-related areas, and for developing spinout companies
-
, scalable and cost-effective vaccine manufacturing—capability that may be applicable to other challenging vaccine targets. Your high-level duties will include: Under the direction of senior research
-
and in vivo studies—to identify novel therapeutic targets for inflammatory vascular diseases. Established in 2009, CICS is dedicated to accelerating the translation of basic cardiovascular research
-
algorithms. Conduct rigorous simulations and live PoC trials to ensure computation offloading algorithms meets URLLC targets for public safety services. Participate in and manage the research project with
-
well as experimental and computational approaches. The ideal candidate will have a strong interest in gene regulatory mechanisms, with a track record of creative research in molecular biology, cell biology, genomics